Edition:
United States

People: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

64.93USD
4:00pm EDT
Change (% chg)

$0.38 (+0.59%)
Prev Close
$64.55
Open
$64.73
Day's High
$65.19
Day's Low
$64.55
Volume
2,157,699
Avg. Vol
2,973,966
52-wk High
$66.80
52-wk Low
$55.10

Schechter, Adam 

Mr. Adam H. Schechter is the Executive Vice President and President - Global Human Health of Merck & Co., Inc. He is responsible for the Company’s global pharmaceutical and vaccine business. Since November 2009 — President, Global Human Health, U.S. Market-Integration Leader, Merck & Co., Inc. — commercial responsibility in the United States for the Company’s portfolio of prescription medicines. Leader for the integration efforts for the Merck/Schering-Plough merger across all divisions and functions. Since August 2007 — President, Global Pharmaceuticals, Global Human Health, Merck & Co., Inc. — global responsibilities for the Company’s atherosclerosis/cardiovascular, diabetes/obesity, oncology, specialty/neuroscience, respiratory, bone, arthritis and analgesia franchises as well as commercial responsibility in the United States for the Company’s portfolio of prescription medicines. Since July 2006 — President, U.S. Human Health, Merck & Co., Inc. — commercial responsibility in the United States for the Company’s portfolio of prescription medicines.

Basic Compensation

Total Annual Compensation, USD 2,107,110
Restricted Stock Awards, USD 2,493,920
Long-Term Incentive Plans, USD --
All Other, USD 3,666,990
Fiscal Year Total, USD 8,268,010

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 89,200 1,807,220.00